| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/17/2003 | WO2003030816A2 Combinatorial anti-acne compositions |
| 04/17/2003 | WO2003030813A2 Anti-irritating rosacea treatment |
| 04/17/2003 | WO2002085943A3 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| 04/17/2003 | WO2002058718A3 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002012341A3 Her-2/neu fusion proteins |
| 04/17/2003 | WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 04/17/2003 | WO2001085210A3 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 04/17/2003 | US20030074691 Resistance to viruses and viroids in transgenic plants and animals expressing dsRNA-binding protein |
| 04/17/2003 | US20030074676 I0nduction of preferential immunoglobulin in mammal; obtain mammal, immunize with tumor necrosis factor, monitor expression of immunoglobulin in milk |
| 04/17/2003 | US20030072829 Bacterial isolates from organisms that respire at least partially through their skin and biologically active extracts derived therefrom |
| 04/17/2003 | US20030072812 Administering at a tumor site in a mammalian subject a pharmaceutically acceptable form of at least one iron compound or complex in a suitable carrier for therapy of breast cancer |
| 04/17/2003 | US20030072796 For activating T lymphocytes in vitro for the treatment of disease conditions |
| 04/17/2003 | US20030072777 Combinatorial anti-acne compositions |
| 04/17/2003 | US20030072767 Compositions and methods for WT1 specific immunotherapy |
| 04/17/2003 | US20030072760 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 04/17/2003 | US20030072759 Administering to a patient afflicted with a gastrointestinal tumor, a murine monoclonal antibody which specifically binds to an epitope of 17-1A antigen, the antibody being administered parenterally in multiple doses |
| 04/17/2003 | US20030072754 CD154 blockade therapy for pancreatic islet tissue transplantation |
| 04/17/2003 | US20030072751 Idiotypic vaccination against b cell lymphoma |
| 04/17/2003 | US20030072749 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve |
| 04/17/2003 | US20030072743 Genetically modifying phagocyte to express an apoptotic cell receptor with enhanced ability to capture apoptotic cells; or increase expression of an apoptotic-cell receptor |
| 04/17/2003 | DE10139783C1 Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung Cell compositions for the treatment of osteoarthritis, as well as processes for their preparation |
| 04/17/2003 | CA2463442A1 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
| 04/17/2003 | CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis |
| 04/17/2003 | CA2462840A1 Pseudopterosin compounds of symbiodinium spp isolated from pseudopterogorgia elisabethae |
| 04/17/2003 | CA2461960A1 Combinatorial anti-acne compositions |
| 04/17/2003 | CA2458392A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/16/2003 | EP1302536A2 Embryonic stem cells and neural progenitor cells derived therefrom |
| 04/16/2003 | EP1302535A1 Heart muscle-like cell sheet, three-dimensional construct, heart muscle-like tissue and process for producing the same |
| 04/16/2003 | EP1302534A1 Cell fraction containing cells capable of differentiating into neural cells |
| 04/16/2003 | EP1302207A2 Method for preparing an antihypertensive agent containing a dipeptide as active ingredient |
| 04/16/2003 | EP1301798A2 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 04/16/2003 | EP1301795A2 Method of identifying and/or isolating stem cells |
| 04/16/2003 | EP1301615A2 Adenovirus vectors comprising introns |
| 04/16/2003 | EP1301614A1 Codon-optimized papilloma virus sequences |
| 04/16/2003 | EP1301613A2 Modified virus having an altered tropism |
| 04/16/2003 | EP1301612A2 Method and composition for targeting an adenoviral vector |
| 04/16/2003 | EP1301593A2 ANTISENSE COMPOSITIONS TARGETED TO $g(b) 1? ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 04/16/2003 | EP1301590A2 Stem cell-like cells |
| 04/16/2003 | EP1301541A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301525A1 Transforming growth factor beta (tgf-beta) blocking agent-treated stem cell composition and method |
| 04/16/2003 | EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 04/16/2003 | EP1301228A2 Deployment system for myocardial cellular material |
| 04/16/2003 | EP1301214A2 Methods of transducing neural cells using lentivirus vectors |
| 04/16/2003 | EP1301203A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 04/16/2003 | EP1301199A2 Methods for therapy of neurodegenerative disease of the brain |
| 04/16/2003 | EP1301195A2 Pharmaceutical use of fibulin-1 |
| 04/16/2003 | EP1239895B1 A process for preparing an autologous platelet gel |
| 04/16/2003 | EP1218022B1 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 04/16/2003 | EP1181047B1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/16/2003 | EP1009442B1 Improvements in or relating to regulation of t cell activation |
| 04/16/2003 | EP0927052B1 Bladder submucosa seeded with cells for tissue reconstruction |
| 04/16/2003 | EP0920322B1 Use of modified autologous blood for the treatment of autoimmune diseases |
| 04/16/2003 | EP0871483B1 Helper virus-free aav production |
| 04/16/2003 | EP0869803B1 Allogeneic paracrine cytokine tumor vaccines |
| 04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 04/16/2003 | EP0789591B1 Methods for identifying individuals suffering from a cellular abnormality |
| 04/16/2003 | EP0648271B1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/16/2003 | EP0591462B1 Universal donor cells |
| 04/16/2003 | CN1411504A Liver tissue source |
| 04/16/2003 | CN1411468A Attenuated microorganisms for treatment of infection |
| 04/16/2003 | CN1410119A Rhubarb ground beetle pill |
| 04/16/2003 | CN1410103A Ointment for eliminating macula and its preparation method |
| 04/16/2003 | CN1410098A Chinese patent medicine for treating cancer |
| 04/16/2003 | CN1410097A Chinese patent medicine for treating mastoncus |
| 04/16/2003 | CN1410094A Ointment for treating nuchal rigidity |
| 04/16/2003 | CN1410088A Medicine for treating apoplexia hemiplegia |
| 04/16/2003 | CN1410077A Application of fur seal oil in preparation of medicine for treating diabetes |
| 04/16/2003 | CN1410076A Application of fur seal oil in preparation of medicine for treating prostatauxe |
| 04/16/2003 | CN1410075A Application of fur seal oil in preparation of medicine for treating lipometabolism disorder (high blood fat) |
| 04/16/2003 | CN1410074A Application of fur seal oil in preparation of medicine for treating acute liver damage |
| 04/16/2003 | CN1410073A Application of fur seal oil in preparation of medicine for treating fatty liver |
| 04/16/2003 | CN1409999A Method for extracting black-bone chicken extract (natural juice) and black-bone chicken extract obtained thereby |
| 04/16/2003 | CN1105571C Hyperostereogeny treating medicine and its preparing process |
| 04/16/2003 | CN1105570C Medicinal composition for curing arthritis and osteoarth ropathy and its preparing method |
| 04/16/2003 | CN1105569C Medicinal composition for stasis of blood |
| 04/16/2003 | CN1105567C Medicine for treating leukemia and its preparing process |
| 04/16/2003 | CN1105566C Chinese patent medicine for treating gastrosis |
| 04/15/2003 | USRE38081 Method of hemodilution facilitated by monitoring oxygenation status |
| 04/15/2003 | US6548299 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 04/15/2003 | US6548241 Storage solution containing photosensitizer for inactivation of biological contaminants |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6547826 Method of organogenesis and tissue regeneration/repair using surgical techniques |
| 04/15/2003 | CA2059979C Complex containing coagulation factor ix |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029445A1 Process for the production of cells exhibiting an islet-beta-cell-like state |
| 04/10/2003 | WO2003029436A2 Ul16 binding protein 4 |
| 04/10/2003 | WO2003029433A2 Chimeric viral vectors for gene therapy |
| 04/10/2003 | WO2003029432A2 Human mesenchymal progenitor cell |
| 04/10/2003 | WO2003029418A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 04/10/2003 | WO2003029417A2 Nutrient medium for maintaining neural cells in injured nervous system |
| 04/10/2003 | WO2003029412A2 Restricted expression lentivial vectors |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029288A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | WO2003028763A1 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 04/10/2003 | WO2003028751A1 Glycoprotein and/or glycomacropeptide containing ophthalmic preparation |
| 04/10/2003 | WO2003028745A1 A composition for lowering the concentration of intestinal pathogenic peptides |
| 04/10/2003 | WO2003028744A1 Process for producing collagen production enhancers and use thereof |
| 04/10/2003 | WO2003028735A1 Estrogen/gestagen combination preparation and application thereof |